Endo International (Portfolio of Generic Products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Endo International (Portfolio of Generic Products) General Information

Description

Portfolio of 24 drug product applications. The portfolio includes 23 approved and 1 pending drug product application, consists of oral solutions with a few semi-solid products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Carmel, NY
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endo International (Portfolio of Generic Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endo International (Portfolio of Generic Products)‘s full profile, request access.

Request a free trial

Endo International (Portfolio of Generic Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Endo International (Portfolio of Generic Products)‘s full profile, request access.

Request a free trial